Literature DB >> 7507781

Aminoguanidine selectively inhibits inducible nitric oxide synthase.

M J Griffiths1, M Messent, R J MacAllister, T W Evans.   

Abstract

1. Endotoxin induces nitric oxide synthase in vascular tissue, including rat main pulmonary artery. Currently available agents that cause inhibition of nitric oxide synthase are relatively non-selective between the constitutive and inducible forms of the enzyme. 2. Aminoguanidine caused a dose-dependent increase in phenylephrine-induced tension in intact and endothelium-denuded pulmonary artery rings from endotoxin-treated rats, but had no effect on sham-treated controls. 3. Contraction caused by aminoguanidine in endothelium-denuded vessels from endotoxin-treated rats was unaffected by indomethacin (10 microM), and by cimetidine and mepyramine (both 10 microM), excluding an effect of aminoguanidine mediated by arachidonic acid metabolites or histamine. 4. Contraction caused by aminoguanidine in endothelium-denuded vessels from endotoxin-treated rats was abolished by L-arginine (2 mM) and L-NG-monomethyl arginine (300 microM), but unaffected by D-arginine and D-NG-monomethyl arginine, suggesting that its action is mediated by the L-arginine/nitric oxide pathway. 5. Aminoguanidine had no effect on acetylcholine-induced relaxation of intact vessels from shamtreated rats. However, relaxation of artery rings from endotoxin-treated rats by L-arginine was competitively inhibited by aminoguanidine.6. These results in isolated main pulmonary arteries of the rat confirm previous reports that aminoguanidine is a selective inhibitor of inducible nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507781      PMCID: PMC2175814          DOI: 10.1111/j.1476-5381.1993.tb13907.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

2.  Diminution of contractile response of the aorta from endotoxin-injected rats.

Authors:  I Wakabayashi; K Hatake; E Kakishita; K Nagai
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

3.  Endotoxin and prevention of hypoxic pulmonary vasoconstriction.

Authors:  E K Weir; J Mlczoch; J T Reeves; R F Grover
Journal:  J Lab Clin Med       Date:  1976-12

4.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.

Authors:  G Julou-Schaeffer; G A Gray; I Fleming; C Schott; J R Parratt; J C Stoclet
Journal:  Am J Physiol       Date:  1990-10

5.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

6.  Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Authors:  C Szabó; J A Mitchell; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.

Authors:  D D Rees; R M Palmer; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

10.  Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.

Authors:  M Hecker; J A Mitchell; H J Harris; M Katsura; C Thiemermann; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

View more
  56 in total

1.  Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase.

Authors:  A Kis; A Végh; J Papp; J Parratt
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

Review 3.  The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995.

Authors:  M P Fink; D Payen
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

4.  High Output Cardiac Failure.

Authors:  Inder S. Anand; Viorel G. Florea
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

5.  Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.

Authors:  J Conger; J Robinette; A Villar; L Raij; P Shultz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis.

Authors:  D Salvemini; S L Settle; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

7.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells.

Authors:  D Kunz; G Walker; I Wiesenberg; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.

Authors:  Javier Carmona-Cortés; Isabel Rodríguez-Gómez; Rosemary Wangensteen; Inmaculada Banegas; Ángel M García-Lora; Andrés Quesada; Antonio Osuna; Félix Vargas
Journal:  Tumour Biol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.